Net profit of Titan Biotech rose 66.17% to Rs 6.73 crore in the quarter ended March 2026 as against Rs 4.05 crore during the previous quarter ended March 2025. Sales rose 38.84% to Rs 48.83 crore in the quarter ended March 2026 as against Rs 35.17 crore during the previous quarter ended March 2025.
For the full year,net profit rose 38.83% to Rs 29.89 crore in the year ended March 2026 as against Rs 21.53 crore during the previous year ended March 2025. Sales rose 31.79% to Rs 206.19 crore in the year ended March 2026 as against Rs 156.45 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 48.83 | 35.17 | 39 | 206.19 | 156.45 | 32 |
| OPM % | 19.89 | 12.99 | - | 18.72 | 16.25 | - |
| PBDT | 11.58 | 5.87 | 97 | 43.10 | 28.54 | 51 |
| PBT | 10.28 | 5.03 | 104 | 38.17 | 24.37 | 57 |
| NP | 6.73 | 4.05 | 66 | 29.89 | 21.53 | 39 |
Powered by Capital Market - Live News
